(en) Lymphomas in older patients require special attention because these patients have potentially curative diffuse large B-cell lymphomas (DLBCLs) but may have other diseases that could alter their ability to tolerate treatment. The incidence of lymphomas in older patients has increased in recent years. As detailed in Table 1, most of the subtypes of lymphomas, with the exception of Burkitt lymphoma, lymphocyte predominant nodular Hodgkin lymphoma and classical Hodgkin lymphoma, increase after the age of 50, with a median age of onset of 67 years. Most frequent entities in this age group are DLBCLs, followed by marginal zone lymphomas and follicular lymphomas. Because of the predominance of DLBCLs, this review will focus mainly on this subtype. [...]
Bron, D., Aurer, I., André, M., Bonnet, C., Caballero, D., Falandry, C., Kimby, E., Soubeyran, P., Zucca, E., Bosly, A., & Coiffier, B. (2017). Unmet needs in the scientific approach to older patients with lymphoma. Haematologica : the hematology journal, 102(6), 972-975. https://doi.org/10.3324/haematol.2017.167619 (Original work published 2017)